PC3 cells |
Function assay |
|
|
|
Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA, IC50=0.113 μM |
21341675 |
F-36P cells |
Proliferation assay |
|
|
|
Antiproliferative activity against human F-36P cells, IC50=0.28 μM |
21341675 |
OCI-AML2 cells |
Proliferation assay |
|
|
|
Antiproliferative activity against human OCI-AML2 cells, IC50=0.35 μM |
21341675 |
K562 cells |
Proliferation assay |
|
|
|
Antiproliferative activity against human K562 cells, IC50=18 μM |
21341675 |
MES-SA |
Cytotoxicity assay |
|
|
|
Cytotoxicity against multidrug-resistant human MES-SA cells, IC50=0.005μM. |
23937981 |
MES-SA/Dx5 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human MES-SA/Dx5 cells, IC50=0.005μM. |
23937981 |
Bowes |
Cytotoxicity assay |
|
|
|
Cytotoxicity against multidrug-resistant human Bowes cells, IC50=0.01μM. |
23937981 |
DU145 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human DU145 cells, IC50=0.02μM. |
23937981 |
Ramos |
Function assay |
|
|
|
Induction of Hsp70 production in human Ramos cells after 5 hrs by ELISA, EC50=0.02μM. |
23937981 |
HL60 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against multidrug-resistant human HL60 cells, IC50=0.05μM. |
23937981 |
MES-SA |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human MES-SA cells, IC50=0.05μM. |
23937981 |
MIP101 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human MIP101 cells, IC50=0.05μM. |
23937981 |
A549 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human A549 cells, IC50=0.1μM. |
23937981 |
Clone A |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human Clone A cells, IC50=0.1μM. |
23937981 |
Bowes |
Cytotoxicity assay |
|
|
|
Cytotoxicity against wild type human Bowes cells, IC50=0.2μM. |
23937981 |
HL60 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human HL60 cells, IC50=0.4μM. |
23937981 |
MDA435 |
Cytotoxicity assay |
|
|
|
Cytotoxicity against human MDA435 cells, IC50=5μM. |
23937981 |
MDA-MB-435 |
Antitumor assay |
25 mg/kg |
|
|
Antitumor activity against human MDA-MB-435 cells xenografted in CD-1 nu/nu mouse assessed as tumor regression at 25 mg/kg, iv qod administered 3 times a week for 2 consecutive weeks |
23937981 |
NOS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOS-1 cell growth in a cell viability assay, IC50=0.0000366μM. |
SANGER |
CAL-51 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-51 cell growth in a cell viability assay, IC50=0.0001264μM. |
SANGER |
ABC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ABC-1 cell growth in a cell viability assay, IC50=0.0003653μM. |
SANGER |
A2780 |
Growth inhibition assay |
|
|
|
Inhibition of human A2780 cell growth in a cell viability assay, IC50=0.0005939μM. |
SANGER |
ES1 |
Growth inhibition assay |
|
|
|
Inhibition of human ES1 cell growth in a cell viability assay, IC50=0.0007491μM. |
SANGER |
HUTU-80 |
Growth inhibition assay |
|
|
|
Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50=0.0007911μM. |
SANGER |
NCI-H292 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H292 cell growth in a cell viability assay, IC50=0.0008859μM. |
SANGER |
NB69 |
Growth inhibition assay |
|
|
|
Inhibition of human NB69 cell growth in a cell viability assay, IC50=0.001218μM. |
SANGER |
ES8 |
Growth inhibition assay |
|
|
|
Inhibition of human ES8 cell growth in a cell viability assay, IC50=0.001317μM. |
SANGER |
BCPAP |
Growth inhibition assay |
|
|
|
Inhibition of human BCPAP cell growth in a cell viability assay, IC50=0.001345μM. |
SANGER |
T-24 |
Growth inhibition assay |
|
|
|
Inhibition of human T-24 cell growth in a cell viability assay, IC50=0.001551μM. |
SANGER |
EW-16 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-16 cell growth in a cell viability assay, IC50=0.001609μM. |
SANGER |
OVCAR-5 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-5 cell growth in a cell viability assay, IC50=0.001835μM. |
SANGER |
SF126 |
Growth inhibition assay |
|
|
|
Inhibition of human SF126 cell growth in a cell viability assay, IC50=0.001954μM. |
SANGER |
KP-4 |
Growth inhibition assay |
|
|
|
Inhibition of human KP-4 cell growth in a cell viability assay, IC50=0.002173μM. |
SANGER |
GAMG |
Growth inhibition assay |
|
|
|
Inhibition of human GAMG cell growth in a cell viability assay, IC50=0.00251μM. |
SANGER |
HOS |
Growth inhibition assay |
|
|
|
Inhibition of human HOS cell growth in a cell viability assay, IC50=0.002531μM. |
SANGER |
CHL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CHL-1 cell growth in a cell viability assay, IC50=0.002811μM. |
SANGER |
AGS |
Growth inhibition assay |
|
|
|
Inhibition of human AGS cell growth in a cell viability assay, IC50=0.002863μM. |
SANGER |
MDA-MB-157 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-157 cell growth in a cell viability assay, IC50=0.002918μM. |
SANGER |
HSC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-3 cell growth in a cell viability assay, IC50=0.003015μM. |
SANGER |
CAL-72 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-72 cell growth in a cell viability assay, IC50=0.003023μM. |
SANGER |
NBsusSR |
Growth inhibition assay |
|
|
|
Inhibition of human NBsusSR cell growth in a cell viability assay, IC50=0.003134μM. |
SANGER |
ES7 |
Growth inhibition assay |
|
|
|
Inhibition of human ES7 cell growth in a cell viability assay, IC50=0.003592μM. |
SANGER |
H-EMC-SS |
Growth inhibition assay |
|
|
|
Inhibition of human H-EMC-SS cell growth in a cell viability assay, IC50=0.003684μM. |
SANGER |
NCI-H1703 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1703 cell growth in a cell viability assay, IC50=0.003685μM. |
SANGER |
BHT-101 |
Growth inhibition assay |
|
|
|
Inhibition of human BHT-101 cell growth in a cell viability assay, IC50=0.00372μM. |
SANGER |
SK-OV-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-OV-3 cell growth in a cell viability assay, IC50=0.003751μM. |
SANGER |
EW-24 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-24 cell growth in a cell viability assay, IC50=0.003835μM. |
SANGER |
PSN1 |
Growth inhibition assay |
|
|
|
Inhibition of human PSN1 cell growth in a cell viability assay, IC50=0.003841μM. |
SANGER |
OVCAR-8 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-8 cell growth in a cell viability assay, IC50=0.003995μM. |
SANGER |
P12-ICHIKAWA |
Growth inhibition assay |
|
|
|
Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50=0.004044μM. |
SANGER |
SW756 |
Growth inhibition assay |
|
|
|
Inhibition of human SW756 cell growth in a cell viability assay, IC50=0.004131μM. |
SANGER |
NCI-H1563 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1563 cell growth in a cell viability assay, IC50=0.004133μM. |
SANGER |
A375 |
Growth inhibition assay |
|
|
|
Inhibition of human A375 cell growth in a cell viability assay, IC50=0.004143μM. |
SANGER |
Ca9-22 |
Growth inhibition assay |
|
|
|
Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50=0.004247μM. |
SANGER |
SW1990 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1990 cell growth in a cell viability assay, IC50=0.004318μM. |
SANGER |
ES4 |
Growth inhibition assay |
|
|
|
Inhibition of human ES4 cell growth in a cell viability assay, IC50=0.004391μM. |
SANGER |
HCE-T |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-T cell growth in a cell viability assay, IC50=0.004451μM. |
SANGER |
MOLT-16 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50=0.004527μM. |
SANGER |
HSC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-4 cell growth in a cell viability assay, IC50=0.004803μM. |
SANGER |
NCI-SNU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-1 cell growth in a cell viability assay, IC50=0.004862μM. |
SANGER |
EW-11 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-11 cell growth in a cell viability assay, IC50=0.004896μM. |
SANGER |
HT-1080 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1080 cell growth in a cell viability assay, IC50=0.004993μM. |
SANGER |
SW1710 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1710 cell growth in a cell viability assay, IC50=0.005164μM. |
SANGER |
EW-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-1 cell growth in a cell viability assay, IC50=0.005237μM. |
SANGER |
BV-173 |
Growth inhibition assay |
|
|
|
Inhibition of human BV-173 cell growth in a cell viability assay, IC50=0.005387μM. |
SANGER |
ChaGo-K-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ChaGo-K-1 cell growth in a cell viability assay, IC50=0.0054μM. |
SANGER |
TE-8 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-8 cell growth in a cell viability assay, IC50=0.005405μM. |
SANGER |
G-401 |
Growth inhibition assay |
|
|
|
Inhibition of human G-401 cell growth in a cell viability assay, IC50=0.005426μM. |
SANGER |
KOSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KOSC-2 cell growth in a cell viability assay, IC50=0.005453μM. |
SANGER |
HuCCT1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuCCT1 cell growth in a cell viability assay, IC50=0.00552μM. |
SANGER |
FADU |
Growth inhibition assay |
|
|
|
Inhibition of human FADU cell growth in a cell viability assay, IC50=0.005663μM. |
SANGER |
MHH-ES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-ES-1 cell growth in a cell viability assay, IC50=0.005692μM. |
SANGER |
ES3 |
Growth inhibition assay |
|
|
|
Inhibition of human ES3 cell growth in a cell viability assay, IC50=0.005793μM. |
SANGER |
OVCAR-4 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50=0.00587μM. |
SANGER |
HD-MY-Z |
Growth inhibition assay |
|
|
|
Inhibition of human HD-MY-Z cell growth in a cell viability assay, IC50=0.005909μM. |
SANGER |
JAR |
Growth inhibition assay |
|
|
|
Inhibition of human JAR cell growth in a cell viability assay, IC50=0.005967μM. |
SANGER |
A427 |
Growth inhibition assay |
|
|
|
Inhibition of human A427 cell growth in a cell viability assay, IC50=0.006067μM. |
SANGER |
697 |
Growth inhibition assay |
|
|
|
Inhibition of human 697 cell growth in a cell viability assay, IC50=0.006126μM. |
SANGER |
OVCAR-3 |
Growth inhibition assay |
|
|
|
Inhibition of human OVCAR-3 cell growth in a cell viability assay, IC50=0.006201μM. |
SANGER |
NB14 |
Growth inhibition assay |
|
|
|
Inhibition of human NB14 cell growth in a cell viability assay, IC50=0.006637μM. |
SANGER |
GB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GB-1 cell growth in a cell viability assay, IC50=0.006709μM. |
SANGER |
COR-L105 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L105 cell growth in a cell viability assay, IC50=0.006764μM. |
SANGER |
647-V |
Growth inhibition assay |
|
|
|
Inhibition of human 647-V cell growth in a cell viability assay, IC50=0.006905μM. |
SANGER |
K5 |
Growth inhibition assay |
|
|
|
Inhibition of human K5 cell growth in a cell viability assay, IC50=0.006999μM. |
SANGER |
DMS-273 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-273 cell growth in a cell viability assay, IC50=0.007057μM. |
SANGER |
UM-UC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human UM-UC-3 cell growth in a cell viability assay, IC50=0.007063μM. |
SANGER |
HEL |
Growth inhibition assay |
|
|
|
Inhibition of human HEL cell growth in a cell viability assay, IC50=0.007077μM. |
SANGER |
KU-19-19 |
Growth inhibition assay |
|
|
|
Inhibition of human KU-19-19 cell growth in a cell viability assay, IC50=0.007094μM. |
SANGER |
MC-IXC |
Growth inhibition assay |
|
|
|
Inhibition of human MC-IXC cell growth in a cell viability assay, IC50=0.007171μM. |
SANGER |
H4 |
Growth inhibition assay |
|
|
|
Inhibition of human H4 cell growth in a cell viability assay, IC50=0.00725μM. |
SANGER |
NUGC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human NUGC-3 cell growth in a cell viability assay, IC50=0.007328μM. |
SANGER |
CHP-212 |
Growth inhibition assay |
|
|
|
Inhibition of human CHP-212 cell growth in a cell viability assay, IC50=0.007342μM. |
SANGER |
SW982 |
Growth inhibition assay |
|
|
|
Inhibition of human SW982 cell growth in a cell viability assay, IC50=0.00744μM. |
SANGER |
C-33-A |
Growth inhibition assay |
|
|
|
Inhibition of human C-33-A cell growth in a cell viability assay, IC50=0.007579μM. |
SANGER |
HGC-27 |
Growth inhibition assay |
|
|
|
Inhibition of human HGC-27 cell growth in a cell viability assay, IC50=0.007592μM. |
SANGER |
VA-ES-BJ |
Growth inhibition assay |
|
|
|
Inhibition of human VA-ES-BJ cell growth in a cell viability assay, IC50=0.007641μM. |
SANGER |
SW13 |
Growth inhibition assay |
|
|
|
Inhibition of human SW13 cell growth in a cell viability assay, IC50=0.007689μM. |
SANGER |
EFO-27 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-27 cell growth in a cell viability assay, IC50=0.007718μM. |
SANGER |
LNCaP-Clone-FGC |
Growth inhibition assay |
|
|
|
Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay, IC50=0.007726μM. |
SANGER |
PC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-3 cell growth in a cell viability assay, IC50=0.007885μM. |
SANGER |
HEC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HEC-1 cell growth in a cell viability assay, IC50=0.008254μM. |
SANGER |
GI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human GI-1 cell growth in a cell viability assay, IC50=0.008261μM. |
SANGER |
EGI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human EGI-1 cell growth in a cell viability assay, IC50=0.008376μM. |
SANGER |
HCC1395 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1395 cell growth in a cell viability assay, IC50=0.008469μM. |
SANGER |
RERF-LC-MS |
Growth inhibition assay |
|
|
|
Inhibition of human RERF-LC-MS cell growth in a cell viability assay, IC50=0.008579μM. |
SANGER |
CP50-MEL-B |
Growth inhibition assay |
|
|
|
Inhibition of human CP50-MEL-B cell growth in a cell viability assay, IC50=0.008626μM. |
SANGER |
CTB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTB-1 cell growth in a cell viability assay, IC50=0.00864μM. |
SANGER |
JEG-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JEG-3 cell growth in a cell viability assay, IC50=0.00884μM. |
SANGER |
PA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PA-1 cell growth in a cell viability assay, IC50=0.008844μM. |
SANGER |
A204 |
Growth inhibition assay |
|
|
|
Inhibition of human A204 cell growth in a cell viability assay, IC50=0.008848μM. |
SANGER |
NCI-H1355 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1355 cell growth in a cell viability assay, IC50=0.008886μM. |
SANGER |
NB17 |
Growth inhibition assay |
|
|
|
Inhibition of human NB17 cell growth in a cell viability assay, IC50=0.008939μM. |
SANGER |
SK-PN-DW |
Growth inhibition assay |
|
|
|
Inhibition of human SK-PN-DW cell growth in a cell viability assay, IC50=0.009023μM. |
SANGER |
NCI-H1693 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1693 cell growth in a cell viability assay, IC50=0.009094μM. |
SANGER |
MPP-89 |
Growth inhibition assay |
|
|
|
Inhibition of human MPP-89 cell growth in a cell viability assay, IC50=0.009133μM. |
SANGER |
8-MG-BA |
Growth inhibition assay |
|
|
|
Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50=0.00914μM. |
SANGER |
SF295 |
Growth inhibition assay |
|
|
|
Inhibition of human SF295 cell growth in a cell viability assay, IC50=0.009195μM. |
SANGER |
COLO-684 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-684 cell growth in a cell viability assay, IC50=0.009208μM. |
SANGER |
DMS-114 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-114 cell growth in a cell viability assay, IC50=0.009431μM. |
SANGER |
SNU-387 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-387 cell growth in a cell viability assay, IC50=0.00949μM. |
SANGER |
KNS-62 |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-62 cell growth in a cell viability assay, IC50=0.009619μM. |
SANGER |
PANC-08-13 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-08-13 cell growth in a cell viability assay, IC50=0.009634μM. |
SANGER |
DBTRG-05MG |
Growth inhibition assay |
|
|
|
Inhibition of human DBTRG-05MG cell growth in a cell viability assay, IC50=0.009769μM. |
SANGER |
769-P |
Growth inhibition assay |
|
|
|
Inhibition of human 769-P cell growth in a cell viability assay, IC50=0.009821μM. |
SANGER |
U251 |
Growth inhibition assay |
|
|
|
Inhibition of human U251 cell growth in a cell viability assay, IC50=0.009856μM. |
SANGER |
HLE |
Growth inhibition assay |
|
|
|
Inhibition of human HLE cell growth in a cell viability assay, IC50=0.009925μM. |
SANGER |
ONS-76 |
Growth inhibition assay |
|
|
|
Inhibition of human ONS-76 cell growth in a cell viability assay, IC50=0.01026μM. |
SANGER |
SK-LU-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LU-1 cell growth in a cell viability assay, IC50=0.01034μM. |
SANGER |
8505C |
Growth inhibition assay |
|
|
|
Inhibition of human 8505C cell growth in a cell viability assay, IC50=0.01053μM. |
SANGER |
MEL-JUSO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-JUSO cell growth in a cell viability assay, IC50=0.01064μM. |
SANGER |
SW1573 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1573 cell growth in a cell viability assay, IC50=0.01068μM. |
SANGER |
LB1047-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50=0.01075μM. |
SANGER |
AN3-CA |
Growth inhibition assay |
|
|
|
Inhibition of human AN3-CA cell growth in a cell viability assay, IC50=0.01079μM. |
SANGER |
CGTH-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50=0.01095μM. |
SANGER |
Saos-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Saos-2 cell growth in a cell viability assay, IC50=0.01108μM. |
SANGER |
22RV1 |
Growth inhibition assay |
|
|
|
Inhibition of human 22RV1 cell growth in a cell viability assay, IC50=0.0113μM. |
SANGER |
IST-MEL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50=0.01134μM. |
SANGER |
A101D |
Growth inhibition assay |
|
|
|
Inhibition of human A101D cell growth in a cell viability assay, IC50=0.01142μM. |
SANGER |
MHH-PREB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50=0.01145μM. |
SANGER |
NEC8 |
Growth inhibition assay |
|
|
|
Inhibition of human NEC8 cell growth in a cell viability assay, IC50=0.01149μM. |
SANGER |
A673 |
Growth inhibition assay |
|
|
|
Inhibition of human A673 cell growth in a cell viability assay, IC50=0.0116μM. |
SANGER |
ACN |
Growth inhibition assay |
|
|
|
Inhibition of human ACN cell growth in a cell viability assay, IC50=0.01172μM. |
SANGER |
ES5 |
Growth inhibition assay |
|
|
|
Inhibition of human ES5 cell growth in a cell viability assay, IC50=0.0118μM. |
SANGER |
Ramos-2G6-4C10 |
Growth inhibition assay |
|
|
|
Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50=0.01199μM. |
SANGER |
D-423MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-423MG cell growth in a cell viability assay, IC50=0.01199μM. |
SANGER |
NCI-H23 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H23 cell growth in a cell viability assay, IC50=0.01222μM. |
SANGER |
L-363 |
Growth inhibition assay |
|
|
|
Inhibition of human L-363 cell growth in a cell viability assay, IC50=0.01227μM. |
SANGER |
SJSA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SJSA-1 cell growth in a cell viability assay, IC50=0.01233μM. |
SANGER |
NCI-H510A |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H510A cell growth in a cell viability assay, IC50=0.01239μM. |
SANGER |
TYK-nu |
Growth inhibition assay |
|
|
|
Inhibition of human TYK-nu cell growth in a cell viability assay, IC50=0.01239μM. |
SANGER |
NCI-H661 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H661 cell growth in a cell viability assay, IC50=0.01247μM. |
SANGER |
YKG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human YKG-1 cell growth in a cell viability assay, IC50=0.01256μM. |
SANGER |
VM-CUB-1 |
Growth inhibition assay |
|
|
|
Inhibition of human VM-CUB-1 cell growth in a cell viability assay, IC50=0.01267μM. |
SANGER |
PFSK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human PFSK-1 cell growth in a cell viability assay, IC50=0.01268μM. |
SANGER |
MZ7-mel |
Growth inhibition assay |
|
|
|
Inhibition of human MZ7-mel cell growth in a cell viability assay, IC50=0.01271μM. |
SANGER |
HOP-92 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-92 cell growth in a cell viability assay, IC50=0.01272μM. |
SANGER |
SF268 |
Growth inhibition assay |
|
|
|
Inhibition of human SF268 cell growth in a cell viability assay, IC50=0.01286μM. |
SANGER |
786-0 |
Growth inhibition assay |
|
|
|
Inhibition of human 786-0 cell growth in a cell viability assay, IC50=0.01287μM. |
SANGER |
TGBC24TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC24TKB cell growth in a cell viability assay, IC50=0.01292μM. |
SANGER |
HT-144 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-144 cell growth in a cell viability assay, IC50=0.01303μM. |
SANGER |
RD |
Growth inhibition assay |
|
|
|
Inhibition of human RD cell growth in a cell viability assay, IC50=0.01311μM. |
SANGER |
CAL-39 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-39 cell growth in a cell viability assay, IC50=0.01329μM. |
SANGER |
NCI-H1755 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1755 cell growth in a cell viability assay, IC50=0.01333μM. |
SANGER |
U031 |
Growth inhibition assay |
|
|
|
Inhibition of human U031 cell growth in a cell viability assay, IC50=0.01342μM. |
SANGER |
RXF393 |
Growth inhibition assay |
|
|
|
Inhibition of human RXF393 cell growth in a cell viability assay, IC50=0.01344μM. |
SANGER |
TCCSUP |
Growth inhibition assay |
|
|
|
Inhibition of human TCCSUP cell growth in a cell viability assay, IC50=0.01346μM. |
SANGER |
MLMA |
Growth inhibition assay |
|
|
|
Inhibition of human MLMA cell growth in a cell viability assay, IC50=0.01358μM. |
SANGER |
NCI-H1395 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1395 cell growth in a cell viability assay, IC50=0.01358μM. |
SANGER |
NCI-H358 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H358 cell growth in a cell viability assay, IC50=0.01365μM. |
SANGER |
NCI-H28 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H28 cell growth in a cell viability assay, IC50=0.01369μM. |
SANGER |
KS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KS-1 cell growth in a cell viability assay, IC50=0.01378μM. |
SANGER |
A2058 |
Growth inhibition assay |
|
|
|
Inhibition of human A2058 cell growth in a cell viability assay, IC50=0.01385μM. |
SANGER |
CAL-120 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-120 cell growth in a cell viability assay, IC50=0.01395μM. |
SANGER |
MKN28 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN28 cell growth in a cell viability assay, IC50=0.01398μM. |
SANGER |
LXF-289 |
Growth inhibition assay |
|
|
|
Inhibition of human LXF-289 cell growth in a cell viability assay, IC50=0.01404μM. |
SANGER |
SK-UT-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50=0.01409μM. |
SANGER |
J82 |
Growth inhibition assay |
|
|
|
Inhibition of human J82 cell growth in a cell viability assay, IC50=0.01413μM. |
SANGER |
COLO-679 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-679 cell growth in a cell viability assay, IC50=0.01414μM. |
SANGER |
SNU-449 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-449 cell growth in a cell viability assay, IC50=0.01419μM. |
SANGER |
SW954 |
Growth inhibition assay |
|
|
|
Inhibition of human SW954 cell growth in a cell viability assay, IC50=0.01421μM. |
SANGER |
RT-112 |
Growth inhibition assay |
|
|
|
Inhibition of human RT-112 cell growth in a cell viability assay, IC50=0.01423μM. |
SANGER |
MN-60 |
Growth inhibition assay |
|
|
|
Inhibition of human MN-60 cell growth in a cell viability assay, IC50=0.01428μM. |
SANGER |
J-RT3-T3-5 |
Growth inhibition assay |
|
|
|
Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay, IC50=0.01439μM. |
SANGER |
NB7 |
Growth inhibition assay |
|
|
|
Inhibition of human NB7 cell growth in a cell viability assay, IC50=0.01439μM. |
SANGER |
LB373-MEL-D |
Growth inhibition assay |
|
|
|
Inhibition of human LB373-MEL-D cell growth in a cell viability assay, IC50=0.01467μM. |
SANGER |
TE-5 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-5 cell growth in a cell viability assay, IC50=0.01504μM. |
SANGER |
SNU-423 |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-423 cell growth in a cell viability assay, IC50=0.01515μM. |
SANGER |
NB10 |
Growth inhibition assay |
|
|
|
Inhibition of human NB10 cell growth in a cell viability assay, IC50=0.01517μM. |
SANGER |
TI-73 |
Growth inhibition assay |
|
|
|
Inhibition of human TI-73 cell growth in a cell viability assay, IC50=0.01522μM. |
SANGER |
D-566MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-566MG cell growth in a cell viability assay, IC50=0.01523μM. |
SANGER |
HN |
Growth inhibition assay |
|
|
|
Inhibition of human HN cell growth in a cell viability assay, IC50=0.01538μM. |
SANGER |
Hs-578-T |
Growth inhibition assay |
|
|
|
Inhibition of human Hs-578-T cell growth in a cell viability assay, IC50=0.01554μM. |
SANGER |
U-266 |
Growth inhibition assay |
|
|
|
Inhibition of human U-266 cell growth in a cell viability assay, IC50=0.01582μM. |
SANGER |
BT-549 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-549 cell growth in a cell viability assay, IC50=0.01583μM. |
SANGER |
GT3TKB |
Growth inhibition assay |
|
|
|
Inhibition of human GT3TKB cell growth in a cell viability assay, IC50=0.016μM. |
SANGER |
G-402 |
Growth inhibition assay |
|
|
|
Inhibition of human G-402 cell growth in a cell viability assay, IC50=0.01617μM. |
SANGER |
ME-180 |
Growth inhibition assay |
|
|
|
Inhibition of human ME-180 cell growth in a cell viability assay, IC50=0.01624μM. |
SANGER |
NCI-H2126 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50=0.01631μM. |
SANGER |
639-V |
Growth inhibition assay |
|
|
|
Inhibition of human 639-V cell growth in a cell viability assay, IC50=0.01674μM. |
SANGER |
T47D |
Growth inhibition assay |
|
|
|
Inhibition of human T47D cell growth in a cell viability assay, IC50=0.01679μM. |
SANGER |
Daoy |
Growth inhibition assay |
|
|
|
Inhibition of human Daoy cell growth in a cell viability assay, IC50=0.0168μM. |
SANGER |
DK-MG |
Growth inhibition assay |
|
|
|
Inhibition of human DK-MG cell growth in a cell viability assay, IC50=0.01706μM. |
SANGER |
MIA-PaCa-2 |
Growth inhibition assay |
|
|
|
Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay, IC50=0.01711μM. |
SANGER |
KNS-81-FD |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-81-FD cell growth in a cell viability assay, IC50=0.01746μM. |
SANGER |
HuH-7 |
Growth inhibition assay |
|
|
|
Inhibition of human HuH-7 cell growth in a cell viability assay, IC50=0.01764μM. |
SANGER |
DOK |
Growth inhibition assay |
|
|
|
Inhibition of human DOK cell growth in a cell viability assay, IC50=0.01792μM. |
SANGER |
MV-4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50=0.018μM. |
SANGER |
NCI-H1048 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1048 cell growth in a cell viability assay, IC50=0.01835μM. |
SANGER |
NCI-H1299 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1299 cell growth in a cell viability assay, IC50=0.01854μM. |
SANGER |
GOTO |
Growth inhibition assay |
|
|
|
Inhibition of human GOTO cell growth in a cell viability assay, IC50=0.01865μM. |
SANGER |
MDA-MB-231 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-231 cell growth in a cell viability assay, IC50=0.01904μM. |
SANGER |
BT-474 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-474 cell growth in a cell viability assay, IC50=0.01921μM. |
SANGER |
DEL |
Growth inhibition assay |
|
|
|
Inhibition of human DEL cell growth in a cell viability assay, IC50=0.01922μM. |
SANGER |
NTERA-S-cl-D1 |
Growth inhibition assay |
|
|
|
Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50=0.01939μM. |
SANGER |
HCC1419 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1419 cell growth in a cell viability assay, IC50=0.01959μM. |
SANGER |
A549 |
Growth inhibition assay |
|
|
|
Inhibition of human A549 cell growth in a cell viability assay, IC50=0.0196μM. |
SANGER |
LK-2 |
Growth inhibition assay |
|
|
|
Inhibition of human LK-2 cell growth in a cell viability assay, IC50=0.01969μM. |
SANGER |
KYSE-410 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-410 cell growth in a cell viability assay, IC50=0.0197μM. |
SANGER |
U-2-OS |
Growth inhibition assay |
|
|
|
Inhibition of human U-2-OS cell growth in a cell viability assay, IC50=0.01973μM. |
SANGER |
EW-13 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-13 cell growth in a cell viability assay, IC50=0.01975μM. |
SANGER |
NMC-G1 |
Growth inhibition assay |
|
|
|
Inhibition of human NMC-G1 cell growth in a cell viability assay, IC50=0.02039μM. |
SANGER |
BFTC-905 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-905 cell growth in a cell viability assay, IC50=0.02046μM. |
SANGER |
M059J |
Growth inhibition assay |
|
|
|
Inhibition of human M059J cell growth in a cell viability assay, IC50=0.02055μM. |
SANGER |
HuP-T4 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T4 cell growth in a cell viability assay, IC50=0.02073μM. |
SANGER |
A172 |
Growth inhibition assay |
|
|
|
Inhibition of human A172 cell growth in a cell viability assay, IC50=0.02089μM. |
SANGER |
RKO |
Growth inhibition assay |
|
|
|
Inhibition of human RKO cell growth in a cell viability assay, IC50=0.02098μM. |
SANGER |
KYSE-140 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-140 cell growth in a cell viability assay, IC50=0.02099μM. |
SANGER |
HuO9 |
Growth inhibition assay |
|
|
|
Inhibition of human HuO9 cell growth in a cell viability assay, IC50=0.02154μM. |
SANGER |
SBC-5 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-5 cell growth in a cell viability assay, IC50=0.02162μM. |
SANGER |
NCI-H2452 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2452 cell growth in a cell viability assay, IC50=0.02172μM. |
SANGER |
HT-1197 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1197 cell growth in a cell viability assay, IC50=0.02182μM. |
SANGER |
UACC-257 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-257 cell growth in a cell viability assay, IC50=0.02197μM. |
SANGER |
CAL-33 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-33 cell growth in a cell viability assay, IC50=0.02223μM. |
SANGER |
Becker |
Growth inhibition assay |
|
|
|
Inhibition of human Becker cell growth in a cell viability assay, IC50=0.02227μM. |
SANGER |
SAS |
Growth inhibition assay |
|
|
|
Inhibition of human SAS cell growth in a cell viability assay, IC50=0.0225μM. |
SANGER |
SCC-25 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-25 cell growth in a cell viability assay, IC50=0.02296μM. |
SANGER |
NB13 |
Growth inhibition assay |
|
|
|
Inhibition of human NB13 cell growth in a cell viability assay, IC50=0.02311μM. |
SANGER |
UACC-62 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-62 cell growth in a cell viability assay, IC50=0.02319μM. |
SANGER |
no-11 |
Growth inhibition assay |
|
|
|
Inhibition of human no-11 cell growth in a cell viability assay, IC50=0.02328μM. |
SANGER |
DSH1 |
Growth inhibition assay |
|
|
|
Inhibition of human DSH1 cell growth in a cell viability assay, IC50=0.02332μM. |
SANGER |
GCT |
Growth inhibition assay |
|
|
|
Inhibition of human GCT cell growth in a cell viability assay, IC50=0.02339μM. |
SANGER |
D-336MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-336MG cell growth in a cell viability assay, IC50=0.02343μM. |
SANGER |
HCC1806 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1806 cell growth in a cell viability assay, IC50=0.02348μM. |
SANGER |
KYSE-180 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-180 cell growth in a cell viability assay, IC50=0.02384μM. |
SANGER |
HuO-3N1 |
Growth inhibition assay |
|
|
|
Inhibition of human HuO-3N1 cell growth in a cell viability assay, IC50=0.02396μM. |
SANGER |
CAKI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAKI-1 cell growth in a cell viability assay, IC50=0.02412μM. |
SANGER |
YH-13 |
Growth inhibition assay |
|
|
|
Inhibition of human YH-13 cell growth in a cell viability assay, IC50=0.02415μM. |
SANGER |
BB65-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human BB65-RCC cell growth in a cell viability assay, IC50=0.02416μM. |
SANGER |
SF539 |
Growth inhibition assay |
|
|
|
Inhibition of human SF539 cell growth in a cell viability assay, IC50=0.02437μM. |
SANGER |
HO-1-N-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HO-1-N-1 cell growth in a cell viability assay, IC50=0.0245μM. |
SANGER |
NCI-H1581 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50=0.02462μM. |
SANGER |
PC-14 |
Growth inhibition assay |
|
|
|
Inhibition of human PC-14 cell growth in a cell viability assay, IC50=0.02473μM. |
SANGER |
D-247MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-247MG cell growth in a cell viability assay, IC50=0.02473μM. |
SANGER |
23132-87 |
Growth inhibition assay |
|
|
|
Inhibition of human 23132-87 cell growth in a cell viability assay, IC50=0.02492μM. |
SANGER |
SCC-15 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-15 cell growth in a cell viability assay, IC50=0.02563μM. |
SANGER |
D-502MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-502MG cell growth in a cell viability assay, IC50=0.02581μM. |
SANGER |
MDA-MB-361 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50=0.02589μM. |
SANGER |
MKN1 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN1 cell growth in a cell viability assay, IC50=0.02597μM. |
SANGER |
RO82-W-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RO82-W-1 cell growth in a cell viability assay, IC50=0.02622μM. |
SANGER |
Mewo |
Growth inhibition assay |
|
|
|
Inhibition of human Mewo cell growth in a cell viability assay, IC50=0.02629μM. |
SANGER |
C32 |
Growth inhibition assay |
|
|
|
Inhibition of human C32 cell growth in a cell viability assay, IC50=0.0263μM. |
SANGER |
NCI-H2030 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2030 cell growth in a cell viability assay, IC50=0.02636μM. |
SANGER |
FTC-133 |
Growth inhibition assay |
|
|
|
Inhibition of human FTC-133 cell growth in a cell viability assay, IC50=0.02701μM. |
SANGER |
S-117 |
Growth inhibition assay |
|
|
|
Inhibition of human S-117 cell growth in a cell viability assay, IC50=0.02741μM. |
SANGER |
A704 |
Growth inhibition assay |
|
|
|
Inhibition of human A704 cell growth in a cell viability assay, IC50=0.02745μM. |
SANGER |
G-361 |
Growth inhibition assay |
|
|
|
Inhibition of human G-361 cell growth in a cell viability assay, IC50=0.02754μM. |
SANGER |
LB831-BLC |
Growth inhibition assay |
|
|
|
Inhibition of human LB831-BLC cell growth in a cell viability assay, IC50=0.02772μM. |
SANGER |
LC-2-ad |
Growth inhibition assay |
|
|
|
Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50=0.02781μM. |
SANGER |
SN12C |
Growth inhibition assay |
|
|
|
Inhibition of human SN12C cell growth in a cell viability assay, IC50=0.02843μM. |
SANGER |
MKN45 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN45 cell growth in a cell viability assay, IC50=0.02868μM. |
SANGER |
NCI-H2347 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2347 cell growth in a cell viability assay, IC50=0.02874μM. |
SANGER |
COLO-792 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-792 cell growth in a cell viability assay, IC50=0.02877μM. |
SANGER |
NCI-H2170 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2170 cell growth in a cell viability assay, IC50=0.02885μM. |
SANGER |
EPLC-272H |
Growth inhibition assay |
|
|
|
Inhibition of human EPLC-272H cell growth in a cell viability assay, IC50=0.02913μM. |
SANGER |
COLO-800 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-800 cell growth in a cell viability assay, IC50=0.02992μM. |
SANGER |
RPMI-8866 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8866 cell growth in a cell viability assay, IC50=0.03002μM. |
SANGER |
SK-N-AS |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-AS cell growth in a cell viability assay, IC50=0.03004μM. |
SANGER |
SW780 |
Growth inhibition assay |
|
|
|
Inhibition of human SW780 cell growth in a cell viability assay, IC50=0.03032μM. |
SANGER |
HTC-C3 |
Growth inhibition assay |
|
|
|
Inhibition of human HTC-C3 cell growth in a cell viability assay, IC50=0.03039μM. |
SANGER |
NCI-H1650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50=0.03043μM. |
SANGER |
NB5 |
Growth inhibition assay |
|
|
|
Inhibition of human NB5 cell growth in a cell viability assay, IC50=0.03066μM. |
SANGER |
NCI-H2228 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50=0.03091μM. |
SANGER |
SiHa |
Growth inhibition assay |
|
|
|
Inhibition of human SiHa cell growth in a cell viability assay, IC50=0.03106μM. |
SANGER |
MCF7 |
Growth inhibition assay |
|
|
|
Inhibition of human MCF7 cell growth in a cell viability assay, IC50=0.03136μM. |
SANGER |
QIMR-WIL |
Growth inhibition assay |
|
|
|
Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50=0.03293μM. |
SANGER |
TGBC1TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC1TKB cell growth in a cell viability assay, IC50=0.03331μM. |
SANGER |
CAL-27 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-27 cell growth in a cell viability assay, IC50=0.0334μM. |
SANGER |
OC-314 |
Growth inhibition assay |
|
|
|
Inhibition of human OC-314 cell growth in a cell viability assay, IC50=0.03348μM. |
SANGER |
WM-115 |
Growth inhibition assay |
|
|
|
Inhibition of human WM-115 cell growth in a cell viability assay, IC50=0.03401μM. |
SANGER |
RPMI-2650 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-2650 cell growth in a cell viability assay, IC50=0.03413μM. |
SANGER |
T98G |
Growth inhibition assay |
|
|
|
Inhibition of human T98G cell growth in a cell viability assay, IC50=0.03431μM. |
SANGER |
MDA-MB-453 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-453 cell growth in a cell viability assay, IC50=0.03469μM. |
SANGER |
ETK-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ETK-1 cell growth in a cell viability assay, IC50=0.03502μM. |
SANGER |
SBC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SBC-1 cell growth in a cell viability assay, IC50=0.03508μM. |
SANGER |
HCC1937 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1937 cell growth in a cell viability assay, IC50=0.03516μM. |
SANGER |
BT-20 |
Growth inhibition assay |
|
|
|
Inhibition of human BT-20 cell growth in a cell viability assay, IC50=0.03521μM. |
SANGER |
BB30-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50=0.03535μM. |
SANGER |
5637 |
Growth inhibition assay |
|
|
|
Inhibition of human 5637 cell growth in a cell viability assay, IC50=0.03546μM. |
SANGER |
NCI-H650 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H650 cell growth in a cell viability assay, IC50=0.03656μM. |
SANGER |
RPMI-7951 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-7951 cell growth in a cell viability assay, IC50=0.03657μM. |
SANGER |
KYSE-270 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-270 cell growth in a cell viability assay, IC50=0.03709μM. |
SANGER |
KARPAS-299 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-299 cell growth in a cell viability assay, IC50=0.03737μM. |
SANGER |
NY |
Growth inhibition assay |
|
|
|
Inhibition of human NY cell growth in a cell viability assay, IC50=0.0376μM. |
SANGER |
AsPC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human AsPC-1 cell growth in a cell viability assay, IC50=0.0377μM. |
SANGER |
HPAF-II |
Growth inhibition assay |
|
|
|
Inhibition of human HPAF-II cell growth in a cell viability assay, IC50=0.03827μM. |
SANGER |
KYSE-450 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-450 cell growth in a cell viability assay, IC50=0.03897μM. |
SANGER |
EKVX |
Growth inhibition assay |
|
|
|
Inhibition of human EKVX cell growth in a cell viability assay, IC50=0.03951μM. |
SANGER |
KG-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KG-1 cell growth in a cell viability assay, IC50=0.03969μM. |
SANGER |
EW-3 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-3 cell growth in a cell viability assay, IC50=0.03988μM. |
SANGER |
PANC-03-27 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50=0.03991μM. |
SANGER |
ES6 |
Growth inhibition assay |
|
|
|
Inhibition of human ES6 cell growth in a cell viability assay, IC50=0.03997μM. |
SANGER |
HCT-116 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-116 cell growth in a cell viability assay, IC50=0.04003μM. |
SANGER |
SW620 |
Growth inhibition assay |
|
|
|
Inhibition of human SW620 cell growth in a cell viability assay, IC50=0.04073μM. |
SANGER |
D-283MED |
Growth inhibition assay |
|
|
|
Inhibition of human D-283MED cell growth in a cell viability assay, IC50=0.04085μM. |
SANGER |
TK10 |
Growth inhibition assay |
|
|
|
Inhibition of human TK10 cell growth in a cell viability assay, IC50=0.04233μM. |
SANGER |
COLO-678 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-678 cell growth in a cell viability assay, IC50=0.04253μM. |
SANGER |
COLO-829 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-829 cell growth in a cell viability assay, IC50=0.04311μM. |
SANGER |
NCI-H2342 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50=0.04327μM. |
SANGER |
EC-GI-10 |
Growth inhibition assay |
|
|
|
Inhibition of human EC-GI-10 cell growth in a cell viability assay, IC50=0.04463μM. |
SANGER |
NCI-H596 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H596 cell growth in a cell viability assay, IC50=0.04484μM. |
SANGER |
MFM-223 |
Growth inhibition assay |
|
|
|
Inhibition of human MFM-223 cell growth in a cell viability assay, IC50=0.0452μM. |
SANGER |
TE-1 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-1 cell growth in a cell viability assay, IC50=0.04597μM. |
SANGER |
RPMI-8226 |
Growth inhibition assay |
|
|
|
Inhibition of human RPMI-8226 cell growth in a cell viability assay, IC50=0.04599μM. |
SANGER |
TE-11 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-11 cell growth in a cell viability assay, IC50=0.04613μM. |
SANGER |
NCI-H1155 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1155 cell growth in a cell viability assay, IC50=0.04621μM. |
SANGER |
A498 |
Growth inhibition assay |
|
|
|
Inhibition of human A498 cell growth in a cell viability assay, IC50=0.04655μM. |
SANGER |
OS-RC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50=0.04771μM. |
SANGER |
ZR-75-30 |
Growth inhibition assay |
|
|
|
Inhibition of human ZR-75-30 cell growth in a cell viability assay, IC50=0.04788μM. |
SANGER |
NB12 |
Growth inhibition assay |
|
|
|
Inhibition of human NB12 cell growth in a cell viability assay, IC50=0.04796μM. |
SANGER |
LS-123 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-123 cell growth in a cell viability assay, IC50=0.04849μM. |
SANGER |
SKG-IIIa |
Growth inhibition assay |
|
|
|
Inhibition of human SKG-IIIa cell growth in a cell viability assay, IC50=0.04982μM. |
SANGER |
NCI-H2405 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2405 cell growth in a cell viability assay, IC50=0.05105μM. |
SANGER |
IST-SL1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50=0.05232μM. |
SANGER |
LAMA-84 |
Growth inhibition assay |
|
|
|
Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50=0.05267μM. |
SANGER |
HCC70 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC70 cell growth in a cell viability assay, IC50=0.05309μM. |
SANGER |
SW626 |
Growth inhibition assay |
|
|
|
Inhibition of human SW626 cell growth in a cell viability assay, IC50=0.05398μM. |
SANGER |
KYSE-70 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-70 cell growth in a cell viability assay, IC50=0.05405μM. |
SANGER |
IST-MES1 |
Growth inhibition assay |
|
|
|
Inhibition of human IST-MES1 cell growth in a cell viability assay, IC50=0.05415μM. |
SANGER |
DJM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human DJM-1 cell growth in a cell viability assay, IC50=0.0543μM. |
SANGER |
LAN-6 |
Growth inhibition assay |
|
|
|
Inhibition of human LAN-6 cell growth in a cell viability assay, IC50=0.05459μM. |
SANGER |
CP66-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human CP66-MEL cell growth in a cell viability assay, IC50=0.05515μM. |
SANGER |
CAL-62 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-62 cell growth in a cell viability assay, IC50=0.05519μM. |
SANGER |
HuP-T3 |
Growth inhibition assay |
|
|
|
Inhibition of human HuP-T3 cell growth in a cell viability assay, IC50=0.05575μM. |
SANGER |
LB2241-RCC |
Growth inhibition assay |
|
|
|
Inhibition of human LB2241-RCC cell growth in a cell viability assay, IC50=0.05636μM. |
SANGER |
NCI-H747 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50=0.0574μM. |
SANGER |
H9 |
Growth inhibition assay |
|
|
|
Inhibition of human H9 cell growth in a cell viability assay, IC50=0.05813μM. |
SANGER |
RH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RH-1 cell growth in a cell viability assay, IC50=0.05817μM. |
SANGER |
AU565 |
Growth inhibition assay |
|
|
|
Inhibition of human AU565 cell growth in a cell viability assay, IC50=0.05907μM. |
SANGER |
HCE-4 |
Growth inhibition assay |
|
|
|
Inhibition of human HCE-4 cell growth in a cell viability assay, IC50=0.0591μM. |
SANGER |
MKN7 |
Growth inhibition assay |
|
|
|
Inhibition of human MKN7 cell growth in a cell viability assay, IC50=0.061μM. |
SANGER |
EoL-1-cell |
Growth inhibition assay |
|
|
|
Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50=0.06203μM. |
SANGER |
SW900 |
Growth inhibition assay |
|
|
|
Inhibition of human SW900 cell growth in a cell viability assay, IC50=0.06212μM. |
SANGER |
CAL-12T |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-12T cell growth in a cell viability assay, IC50=0.063μM. |
SANGER |
NCI-H2052 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2052 cell growth in a cell viability assay, IC50=0.06331μM. |
SANGER |
BFTC-909 |
Growth inhibition assay |
|
|
|
Inhibition of human BFTC-909 cell growth in a cell viability assay, IC50=0.0635μM. |
SANGER |
KP-N-YN |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YN cell growth in a cell viability assay, IC50=0.06561μM. |
SANGER |
HL-60 |
Growth inhibition assay |
|
|
|
Inhibition of human HL-60 cell growth in a cell viability assay, IC50=0.06677μM. |
SANGER |
LB2518-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50=0.06694μM. |
SANGER |
Detroit562 |
Growth inhibition assay |
|
|
|
Inhibition of human Detroit562 cell growth in a cell viability assay, IC50=0.0689μM. |
SANGER |
MHH-NB-11 |
Growth inhibition assay |
|
|
|
Inhibition of human MHH-NB-11 cell growth in a cell viability assay, IC50=0.06913μM. |
SANGER |
YAPC |
Growth inhibition assay |
|
|
|
Inhibition of human YAPC cell growth in a cell viability assay, IC50=0.07034μM. |
SANGER |
COLO-824 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-824 cell growth in a cell viability assay, IC50=0.07181μM. |
SANGER |
CAL-85-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50=0.07266μM. |
SANGER |
SK-MEL-2 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-2 cell growth in a cell viability assay, IC50=0.07316μM. |
SANGER |
RH-18 |
Growth inhibition assay |
|
|
|
Inhibition of human RH-18 cell growth in a cell viability assay, IC50=0.07417μM. |
SANGER |
EW-22 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-22 cell growth in a cell viability assay, IC50=0.07468μM. |
SANGER |
SK-NEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50=0.07614μM. |
SANGER |
RVH-421 |
Growth inhibition assay |
|
|
|
Inhibition of human RVH-421 cell growth in a cell viability assay, IC50=0.07618μM. |
SANGER |
OMC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human OMC-1 cell growth in a cell viability assay, IC50=0.07714μM. |
SANGER |
LoVo |
Growth inhibition assay |
|
|
|
Inhibition of human LoVo cell growth in a cell viability assay, IC50=0.07856μM. |
SANGER |
D-392MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-392MG cell growth in a cell viability assay, IC50=0.07865μM. |
SANGER |
HCC1187 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1187 cell growth in a cell viability assay, IC50=0.07933μM. |
SANGER |
SK-MEL-28 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-28 cell growth in a cell viability assay, IC50=0.07974μM. |
SANGER |
KP-N-YS |
Growth inhibition assay |
|
|
|
Inhibition of human KP-N-YS cell growth in a cell viability assay, IC50=0.07987μM. |
SANGER |
SK-N-FI |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-FI cell growth in a cell viability assay, IC50=0.08148μM. |
SANGER |
OAW-42 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-42 cell growth in a cell viability assay, IC50=0.08159μM. |
SANGER |
LS-513 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-513 cell growth in a cell viability assay, IC50=0.08202μM. |
SANGER |
SW1088 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1088 cell growth in a cell viability assay, IC50=0.08214μM. |
SANGER |
EFM-19 |
Growth inhibition assay |
|
|
|
Inhibition of human EFM-19 cell growth in a cell viability assay, IC50=0.08252μM. |
SANGER |
NCI-H1651 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1651 cell growth in a cell viability assay, IC50=0.08292μM. |
SANGER |
BPH-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BPH-1 cell growth in a cell viability assay, IC50=0.08314μM. |
SANGER |
MMAC-SF |
Growth inhibition assay |
|
|
|
Inhibition of human MMAC-SF cell growth in a cell viability assay, IC50=0.08429μM. |
SANGER |
IA-LM |
Growth inhibition assay |
|
|
|
Inhibition of human IA-LM cell growth in a cell viability assay, IC50=0.08443μM. |
SANGER |
A3-KAW |
Growth inhibition assay |
|
|
|
Inhibition of human A3-KAW cell growth in a cell viability assay, IC50=0.08648μM. |
SANGER |
NCI-H1437 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1437 cell growth in a cell viability assay, IC50=0.08766μM. |
SANGER |
LN-405 |
Growth inhibition assay |
|
|
|
Inhibition of human LN-405 cell growth in a cell viability assay, IC50=0.08779μM. |
SANGER |
NCI-H446 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H446 cell growth in a cell viability assay, IC50=0.09008μM. |
SANGER |
NCI-H1092 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1092 cell growth in a cell viability assay, IC50=0.09011μM. |
SANGER |
KYSE-150 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-150 cell growth in a cell viability assay, IC50=0.09498μM. |
SANGER |
KALS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KALS-1 cell growth in a cell viability assay, IC50=0.09625μM. |
SANGER |
SJRH30 |
Growth inhibition assay |
|
|
|
Inhibition of human SJRH30 cell growth in a cell viability assay, IC50=0.09996μM. |
SANGER |
LS-411N |
Growth inhibition assay |
|
|
|
Inhibition of human LS-411N cell growth in a cell viability assay, IC50=0.10177μM. |
SANGER |
ESS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ESS-1 cell growth in a cell viability assay, IC50=0.10214μM. |
SANGER |
C2BBe1 |
Growth inhibition assay |
|
|
|
Inhibition of human C2BBe1 cell growth in a cell viability assay, IC50=0.10267μM. |
SANGER |
KYSE-520 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-520 cell growth in a cell viability assay, IC50=0.10382μM. |
SANGER |
IGROV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50=0.10398μM. |
SANGER |
MOLT-4 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50=0.10468μM. |
SANGER |
MEG-01 |
Growth inhibition assay |
|
|
|
Inhibition of human MEG-01 cell growth in a cell viability assay, IC50=0.10505μM. |
SANGER |
SNB75 |
Growth inhibition assay |
|
|
|
Inhibition of human SNB75 cell growth in a cell viability assay, IC50=0.10509μM. |
SANGER |
SW837 |
Growth inhibition assay |
|
|
|
Inhibition of human SW837 cell growth in a cell viability assay, IC50=0.10658μM. |
SANGER |
GMS-10 |
Growth inhibition assay |
|
|
|
Inhibition of human GMS-10 cell growth in a cell viability assay, IC50=0.10669μM. |
SANGER |
BHY |
Growth inhibition assay |
|
|
|
Inhibition of human BHY cell growth in a cell viability assay, IC50=0.10706μM. |
SANGER |
HSC-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HSC-2 cell growth in a cell viability assay, IC50=0.1074μM. |
SANGER |
A4-Fuk |
Growth inhibition assay |
|
|
|
Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50=0.10761μM. |
SANGER |
VMRC-RCZ |
Growth inhibition assay |
|
|
|
Inhibition of human VMRC-RCZ cell growth in a cell viability assay, IC50=0.10762μM. |
SANGER |
SW48 |
Growth inhibition assay |
|
|
|
Inhibition of human SW48 cell growth in a cell viability assay, IC50=0.10778μM. |
SANGER |
PANC-10-05 |
Growth inhibition assay |
|
|
|
Inhibition of human PANC-10-05 cell growth in a cell viability assay, IC50=0.10979μM. |
SANGER |
KYSE-510 |
Growth inhibition assay |
|
|
|
Inhibition of human KYSE-510 cell growth in a cell viability assay, IC50=0.11035μM. |
SANGER |
HCC2998 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2998 cell growth in a cell viability assay, IC50=0.11066μM. |
SANGER |
SW962 |
Growth inhibition assay |
|
|
|
Inhibition of human SW962 cell growth in a cell viability assay, IC50=0.11128μM. |
SANGER |
DU-4475 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-4475 cell growth in a cell viability assay, IC50=0.1117μM. |
SANGER |
CAS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAS-1 cell growth in a cell viability assay, IC50=0.11615μM. |
SANGER |
BEN |
Growth inhibition assay |
|
|
|
Inhibition of human BEN cell growth in a cell viability assay, IC50=0.11639μM. |
SANGER |
TE-9 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-9 cell growth in a cell viability assay, IC50=0.11735μM. |
SANGER |
SCC-9 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-9 cell growth in a cell viability assay, IC50=0.1207μM. |
SANGER |
LU-139 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-139 cell growth in a cell viability assay, IC50=0.12082μM. |
SANGER |
M14 |
Growth inhibition assay |
|
|
|
Inhibition of human M14 cell growth in a cell viability assay, IC50=0.12231μM. |
SANGER |
HOP-62 |
Growth inhibition assay |
|
|
|
Inhibition of human HOP-62 cell growth in a cell viability assay, IC50=0.12241μM. |
SANGER |
NCI-H720 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50=0.12372μM. |
SANGER |
NCI-H810 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H810 cell growth in a cell viability assay, IC50=0.12501μM. |
SANGER |
BB49-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50=0.12558μM. |
SANGER |
A431 |
Growth inhibition assay |
|
|
|
Inhibition of human A431 cell growth in a cell viability assay, IC50=0.12588μM. |
SANGER |
HAL-01 |
Growth inhibition assay |
|
|
|
Inhibition of human HAL-01 cell growth in a cell viability assay, IC50=0.12809μM. |
SANGER |
NCI-H2122 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2122 cell growth in a cell viability assay, IC50=0.13028μM. |
SANGER |
NCI-H226 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H226 cell growth in a cell viability assay, IC50=0.13147μM. |
SANGER |
NH-12 |
Growth inhibition assay |
|
|
|
Inhibition of human NH-12 cell growth in a cell viability assay, IC50=0.13425μM. |
SANGER |
NCI-H520 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H520 cell growth in a cell viability assay, IC50=0.13483μM. |
SANGER |
OCI-AML2 |
Growth inhibition assay |
|
|
|
Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50=0.13558μM. |
SANGER |
MDA-MB-415 |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-415 cell growth in a cell viability assay, IC50=0.13655μM. |
SANGER |
TE-6 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-6 cell growth in a cell viability assay, IC50=0.139μM. |
SANGER |
SW1783 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1783 cell growth in a cell viability assay, IC50=0.13904μM. |
SANGER |
DB |
Growth inhibition assay |
|
|
|
Inhibition of human DB cell growth in a cell viability assay, IC50=0.1414μM. |
SANGER |
NB6 |
Growth inhibition assay |
|
|
|
Inhibition of human NB6 cell growth in a cell viability assay, IC50=0.14232μM. |
SANGER |
MZ1-PC |
Growth inhibition assay |
|
|
|
Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50=0.14379μM. |
SANGER |
KMOE-2 |
Growth inhibition assay |
|
|
|
Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50=0.14527μM. |
SANGER |
EFO-21 |
Growth inhibition assay |
|
|
|
Inhibition of human EFO-21 cell growth in a cell viability assay, IC50=0.14938μM. |
SANGER |
HCT-15 |
Growth inhibition assay |
|
|
|
Inhibition of human HCT-15 cell growth in a cell viability assay, IC50=0.15005μM. |
SANGER |
MS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human MS-1 cell growth in a cell viability assay, IC50=0.1657μM. |
SANGER |
AM-38 |
Growth inhibition assay |
|
|
|
Inhibition of human AM-38 cell growth in a cell viability assay, IC50=0.16878μM. |
SANGER |
LOXIMVI |
Growth inhibition assay |
|
|
|
Inhibition of human LOXIMVI cell growth in a cell viability assay, IC50=0.17147μM. |
SANGER |
COLO-741 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-741 cell growth in a cell viability assay, IC50=0.17614μM. |
SANGER |
KINGS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KINGS-1 cell growth in a cell viability assay, IC50=0.17712μM. |
SANGER |
NCI-H1623 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1623 cell growth in a cell viability assay, IC50=0.17935μM. |
SANGER |
NCI-H1838 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1838 cell growth in a cell viability assay, IC50=0.18381μM. |
SANGER |
COLO-680N |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-680N cell growth in a cell viability assay, IC50=0.18702μM. |
SANGER |
NCI-H1573 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1573 cell growth in a cell viability assay, IC50=0.1888μM. |
SANGER |
SK-N-DZ |
Growth inhibition assay |
|
|
|
Inhibition of human SK-N-DZ cell growth in a cell viability assay, IC50=0.18927μM. |
SANGER |
8305C |
Growth inhibition assay |
|
|
|
Inhibition of human 8305C cell growth in a cell viability assay, IC50=0.1925μM. |
SANGER |
OCUB-M |
Growth inhibition assay |
|
|
|
Inhibition of human OCUB-M cell growth in a cell viability assay, IC50=0.19545μM. |
SANGER |
LB771-HNC |
Growth inhibition assay |
|
|
|
Inhibition of human LB771-HNC cell growth in a cell viability assay, IC50=0.20018μM. |
SANGER |
NCI-H1793 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1793 cell growth in a cell viability assay, IC50=0.2097μM. |
SANGER |
HT-3 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-3 cell growth in a cell viability assay, IC50=0.21164μM. |
SANGER |
LCLC-97TM1 |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-97TM1 cell growth in a cell viability assay, IC50=0.21748μM. |
SANGER |
TE-12 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-12 cell growth in a cell viability assay, IC50=0.22078μM. |
SANGER |
HCC2218 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC2218 cell growth in a cell viability assay, IC50=0.22093μM. |
SANGER |
GP5d |
Growth inhibition assay |
|
|
|
Inhibition of human GP5d cell growth in a cell viability assay, IC50=0.2262μM. |
SANGER |
SNU-C2B |
Growth inhibition assay |
|
|
|
Inhibition of human SNU-C2B cell growth in a cell viability assay, IC50=0.22661μM. |
SANGER |
U-87-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-87-MG cell growth in a cell viability assay, IC50=0.22753μM. |
SANGER |
HH |
Growth inhibition assay |
|
|
|
Inhibition of human HH cell growth in a cell viability assay, IC50=0.22843μM. |
SANGER |
SH-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SH-4 cell growth in a cell viability assay, IC50=0.23264μM. |
SANGER |
LCLC-103H |
Growth inhibition assay |
|
|
|
Inhibition of human LCLC-103H cell growth in a cell viability assay, IC50=0.23712μM. |
SANGER |
KNS-42 |
Growth inhibition assay |
|
|
|
Inhibition of human KNS-42 cell growth in a cell viability assay, IC50=0.24283μM. |
SANGER |
CW-2 |
Growth inhibition assay |
|
|
|
Inhibition of human CW-2 cell growth in a cell viability assay, IC50=0.25767μM. |
SANGER |
NCI-N87 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-N87 cell growth in a cell viability assay, IC50=0.2642μM. |
SANGER |
OAW-28 |
Growth inhibition assay |
|
|
|
Inhibition of human OAW-28 cell growth in a cell viability assay, IC50=0.28348μM. |
SANGER |
NCI-H1648 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50=0.28554μM. |
SANGER |
D-263MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-263MG cell growth in a cell viability assay, IC50=0.28767μM. |
SANGER |
RS4-11 |
Growth inhibition assay |
|
|
|
Inhibition of human RS4-11 cell growth in a cell viability assay, IC50=0.28947μM. |
SANGER |
GI-ME-N |
Growth inhibition assay |
|
|
|
Inhibition of human GI-ME-N cell growth in a cell viability assay, IC50=0.29033μM. |
SANGER |
JVM-3 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-3 cell growth in a cell viability assay, IC50=0.29281μM. |
SANGER |
MEL-HO |
Growth inhibition assay |
|
|
|
Inhibition of human MEL-HO cell growth in a cell viability assay, IC50=0.30023μM. |
SANGER |
MSTO-211H |
Growth inhibition assay |
|
|
|
Inhibition of human MSTO-211H cell growth in a cell viability assay, IC50=0.30254μM. |
SANGER |
NCI-H1792 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1792 cell growth in a cell viability assay, IC50=0.30568μM. |
SANGER |
TE-10 |
Growth inhibition assay |
|
|
|
Inhibition of human TE-10 cell growth in a cell viability assay, IC50=0.31694μM. |
SANGER |
NCI-H2009 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50=0.31749μM. |
SANGER |
DOHH-2 |
Growth inhibition assay |
|
|
|
Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50=0.32805μM. |
SANGER |
GCIY |
Growth inhibition assay |
|
|
|
Inhibition of human GCIY cell growth in a cell viability assay, IC50=0.32874μM. |
SANGER |
SCH |
Growth inhibition assay |
|
|
|
Inhibition of human SCH cell growth in a cell viability assay, IC50=0.3391μM. |
SANGER |
KLE |
Growth inhibition assay |
|
|
|
Inhibition of human KLE cell growth in a cell viability assay, IC50=0.38036μM. |
SANGER |
BE-13 |
Growth inhibition assay |
|
|
|
Inhibition of human BE-13 cell growth in a cell viability assay, IC50=0.39158μM. |
SANGER |
CAMA-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAMA-1 cell growth in a cell viability assay, IC50=0.39459μM. |
SANGER |
HC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human HC-1 cell growth in a cell viability assay, IC50=0.39991μM. |
SANGER |
LU-134-A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-134-A cell growth in a cell viability assay, IC50=0.40045μM. |
SANGER |
HCC38 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC38 cell growth in a cell viability assay, IC50=0.41829μM. |
SANGER |
SW872 |
Growth inhibition assay |
|
|
|
Inhibition of human SW872 cell growth in a cell viability assay, IC50=0.44657μM. |
SANGER |
BxPC-3 |
Growth inhibition assay |
|
|
|
Inhibition of human BxPC-3 cell growth in a cell viability assay, IC50=0.47501μM. |
SANGER |
UACC-893 |
Growth inhibition assay |
|
|
|
Inhibition of human UACC-893 cell growth in a cell viability assay, IC50=0.48439μM. |
SANGER |
KURAMOCHI |
Growth inhibition assay |
|
|
|
Inhibition of human KURAMOCHI cell growth in a cell viability assay, IC50=0.48728μM. |
SANGER |
DU-145 |
Growth inhibition assay |
|
|
|
Inhibition of human DU-145 cell growth in a cell viability assay, IC50=0.50043μM. |
SANGER |
SK-MES-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MES-1 cell growth in a cell viability assay, IC50=0.50677μM. |
SANGER |
NKM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NKM-1 cell growth in a cell viability assay, IC50=0.50925μM. |
SANGER |
TGBC11TKB |
Growth inhibition assay |
|
|
|
Inhibition of human TGBC11TKB cell growth in a cell viability assay, IC50=0.51476μM. |
SANGER |
HT-1376 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-1376 cell growth in a cell viability assay, IC50=0.53816μM. |
SANGER |
LU-135 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-135 cell growth in a cell viability assay, IC50=0.54563μM. |
SANGER |
SCC-4 |
Growth inhibition assay |
|
|
|
Inhibition of human SCC-4 cell growth in a cell viability assay, IC50=0.54737μM. |
SANGER |
BALL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human BALL-1 cell growth in a cell viability assay, IC50=0.55558μM. |
SANGER |
NCI-H1304 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1304 cell growth in a cell viability assay, IC50=0.55573μM. |
SANGER |
CaR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CaR-1 cell growth in a cell viability assay, IC50=0.58618μM. |
SANGER |
GR-ST |
Growth inhibition assay |
|
|
|
Inhibition of human GR-ST cell growth in a cell viability assay, IC50=0.6283μM. |
SANGER |
COR-L88 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L88 cell growth in a cell viability assay, IC50=0.64357μM. |
SANGER |
NCI-H526 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H526 cell growth in a cell viability assay, IC50=0.67186μM. |
SANGER |
MZ2-MEL |
Growth inhibition assay |
|
|
|
Inhibition of human MZ2-MEL cell growth in a cell viability assay, IC50=0.71038μM. |
SANGER |
MDA-MB-175-VII |
Growth inhibition assay |
|
|
|
Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay, IC50=0.72931μM. |
SANGER |
KGN |
Growth inhibition assay |
|
|
|
Inhibition of human KGN cell growth in a cell viability assay, IC50=0.75883μM. |
SANGER |
KARPAS-45 |
Growth inhibition assay |
|
|
|
Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50=0.76422μM. |
SANGER |
SK-LMS-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50=0.77309μM. |
SANGER |
MFE-280 |
Growth inhibition assay |
|
|
|
Inhibition of human MFE-280 cell growth in a cell viability assay, IC50=0.80193μM. |
SANGER |
ALL-PO |
Growth inhibition assay |
|
|
|
Inhibition of human ALL-PO cell growth in a cell viability assay, IC50=0.8079μM. |
SANGER |
DoTc2-4510 |
Growth inhibition assay |
|
|
|
Inhibition of human DoTc2-4510 cell growth in a cell viability assay, IC50=0.83126μM. |
SANGER |
SW1417 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1417 cell growth in a cell viability assay, IC50=0.84154μM. |
SANGER |
KE-37 |
Growth inhibition assay |
|
|
|
Inhibition of human KE-37 cell growth in a cell viability assay, IC50=0.87226μM. |
SANGER |
GAK |
Growth inhibition assay |
|
|
|
Inhibition of human GAK cell growth in a cell viability assay, IC50=0.91357μM. |
SANGER |
SK-MEL-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-1 cell growth in a cell viability assay, IC50=0.94883μM. |
SANGER |
HT |
Growth inhibition assay |
|
|
|
Inhibition of human HT cell growth in a cell viability assay, IC50=0.96058μM. |
SANGER |
LU-99A |
Growth inhibition assay |
|
|
|
Inhibition of human LU-99A cell growth in a cell viability assay, IC50=0.98114μM. |
SANGER |
EW-18 |
Growth inhibition assay |
|
|
|
Inhibition of human EW-18 cell growth in a cell viability assay, IC50=0.99505μM. |
SANGER |
P30-OHK |
Growth inhibition assay |
|
|
|
Inhibition of human P30-OHK cell growth in a cell viability assay, IC50=1.06027μM. |
SANGER |
CAPAN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CAPAN-1 cell growth in a cell viability assay, IC50=1.06876μM. |
SANGER |
SK-MEL-24 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-24 cell growth in a cell viability assay, IC50=1.0762μM. |
SANGER |
ML-2 |
Growth inhibition assay |
|
|
|
Inhibition of human ML-2 cell growth in a cell viability assay, IC50=1.14212μM. |
SANGER |
SK-HEP-1 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-HEP-1 cell growth in a cell viability assay, IC50=1.15753μM. |
SANGER |
HT55 |
Growth inhibition assay |
|
|
|
Inhibition of human HT55 cell growth in a cell viability assay, IC50=1.17705μM. |
SANGER |
Calu-6 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-6 cell growth in a cell viability assay, IC50=1.19035μM. |
SANGER |
Ca-Ski |
Growth inhibition assay |
|
|
|
Inhibition of human Ca-Ski cell growth in a cell viability assay, IC50=1.24599μM. |
SANGER |
CAL-54 |
Growth inhibition assay |
|
|
|
Inhibition of human CAL-54 cell growth in a cell viability assay, IC50=1.28131μM. |
SANGER |
HMV-II |
Growth inhibition assay |
|
|
|
Inhibition of human HMV-II cell growth in a cell viability assay, IC50=1.30192μM. |
SANGER |
DMS-79 |
Growth inhibition assay |
|
|
|
Inhibition of human DMS-79 cell growth in a cell viability assay, IC50=1.35288μM. |
SANGER |
NCI-H2291 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2291 cell growth in a cell viability assay, IC50=1.35312μM. |
SANGER |
SK-MEL-3 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50=1.42951μM. |
SANGER |
COR-L23 |
Growth inhibition assay |
|
|
|
Inhibition of human COR-L23 cell growth in a cell viability assay, IC50=1.4298μM. |
SANGER |
SHP-77 |
Growth inhibition assay |
|
|
|
Inhibition of human SHP-77 cell growth in a cell viability assay, IC50=1.45832μM. |
SANGER |
KM12 |
Growth inhibition assay |
|
|
|
Inhibition of human KM12 cell growth in a cell viability assay, IC50=1.47664μM. |
SANGER |
K-562 |
Growth inhibition assay |
|
|
|
Inhibition of human K-562 cell growth in a cell viability assay, IC50=1.47985μM. |
SANGER |
SW1463 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1463 cell growth in a cell viability assay, IC50=1.56644μM. |
SANGER |
MC116 |
Growth inhibition assay |
|
|
|
Inhibition of human MC116 cell growth in a cell viability assay, IC50=1.59879μM. |
SANGER |
no-10 |
Growth inhibition assay |
|
|
|
Inhibition of human no-10 cell growth in a cell viability assay, IC50=1.60982μM. |
SANGER |
T84 |
Growth inhibition assay |
|
|
|
Inhibition of human T84 cell growth in a cell viability assay, IC50=1.7516μM. |
SANGER |
IGR-1 |
Growth inhibition assay |
|
|
|
Inhibition of human IGR-1 cell growth in a cell viability assay, IC50=1.75671μM. |
SANGER |
U-118-MG |
Growth inhibition assay |
|
|
|
Inhibition of human U-118-MG cell growth in a cell viability assay, IC50=1.88558μM. |
SANGER |
NCI-H2087 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2087 cell growth in a cell viability assay, IC50=1.89044μM. |
SANGER |
D-542MG |
Growth inhibition assay |
|
|
|
Inhibition of human D-542MG cell growth in a cell viability assay, IC50=1.90441μM. |
SANGER |
NCI-H727 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H727 cell growth in a cell viability assay, IC50=1.94908μM. |
SANGER |
SW684 |
Growth inhibition assay |
|
|
|
Inhibition of human SW684 cell growth in a cell viability assay, IC50=2.03866μM. |
SANGER |
Capan-2 |
Growth inhibition assay |
|
|
|
Inhibition of human Capan-2 cell growth in a cell viability assay, IC50=2.04183μM. |
SANGER |
HT-29 |
Growth inhibition assay |
|
|
|
Inhibition of human HT-29 cell growth in a cell viability assay, IC50=2.04276μM. |
SANGER |
KASUMI-1 |
Growth inhibition assay |
|
|
|
Inhibition of human KASUMI-1 cell growth in a cell viability assay, IC50=2.09155μM. |
SANGER |
ATN-1 |
Growth inhibition assay |
|
|
|
Inhibition of human ATN-1 cell growth in a cell viability assay, IC50=2.0956μM. |
SANGER |
JVM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human JVM-2 cell growth in a cell viability assay, IC50=2.14047μM. |
SANGER |
SK-MEL-30 |
Growth inhibition assay |
|
|
|
Inhibition of human SK-MEL-30 cell growth in a cell viability assay, IC50=2.38457μM. |
SANGER |
COLO-668 |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-668 cell growth in a cell viability assay, IC50=2.50458μM. |
SANGER |
EM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human EM-2 cell growth in a cell viability assay, IC50=2.51815μM. |
SANGER |
UMC-11 |
Growth inhibition assay |
|
|
|
Inhibition of human UMC-11 cell growth in a cell viability assay, IC50=2.60698μM. |
SANGER |
MG-63 |
Growth inhibition assay |
|
|
|
Inhibition of human MG-63 cell growth in a cell viability assay, IC50=2.8112μM. |
SANGER |
NCI-SNU-5 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-SNU-5 cell growth in a cell viability assay, IC50=2.863μM. |
SANGER |
NOMO-1 |
Growth inhibition assay |
|
|
|
Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50=2.90568μM. |
SANGER |
NCI-H209 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50=3.00673μM. |
SANGER |
CTV-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CTV-1 cell growth in a cell viability assay, IC50=3.01648μM. |
SANGER |
NCI-H1770 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50=3.02207μM. |
SANGER |
RCM-1 |
Growth inhibition assay |
|
|
|
Inhibition of human RCM-1 cell growth in a cell viability assay, IC50=3.03156μM. |
SANGER |
Calu-3 |
Growth inhibition assay |
|
|
|
Inhibition of human Calu-3 cell growth in a cell viability assay, IC50=3.16226μM. |
SANGER |
NCI-H630 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H630 cell growth in a cell viability assay, IC50=3.43203μM. |
SANGER |
SW1116 |
Growth inhibition assay |
|
|
|
Inhibition of human SW1116 cell growth in a cell viability assay, IC50=3.62799μM. |
SANGER |
RMG-I |
Growth inhibition assay |
|
|
|
Inhibition of human RMG-I cell growth in a cell viability assay, IC50=3.84056μM. |
SANGER |
RCC10RGB |
Growth inhibition assay |
|
|
|
Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50=4.53554μM. |
SANGER |
C3A |
Growth inhibition assay |
|
|
|
Inhibition of human C3A cell growth in a cell viability assay, IC50=4.63097μM. |
SANGER |
C8166 |
Growth inhibition assay |
|
|
|
Inhibition of human C8166 cell growth in a cell viability assay, IC50=4.94603μM. |
SANGER |
MOLT-13 |
Growth inhibition assay |
|
|
|
Inhibition of human MOLT-13 cell growth in a cell viability assay, IC50=5.5543μM. |
SANGER |
NCI-H2029 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H2029 cell growth in a cell viability assay, IC50=5.59003μM. |
SANGER |
HDLM-2 |
Growth inhibition assay |
|
|
|
Inhibition of human HDLM-2 cell growth in a cell viability assay, IC50=5.67384μM. |
SANGER |
ACHN |
Growth inhibition assay |
|
|
|
Inhibition of human ACHN cell growth in a cell viability assay, IC50=5.71551μM. |
SANGER |
NCI-H69 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H69 cell growth in a cell viability assay, IC50=5.96973μM. |
SANGER |
ECC10 |
Growth inhibition assay |
|
|
|
Inhibition of human ECC10 cell growth in a cell viability assay, IC50=6.27244μM. |
SANGER |
CFPAC-1 |
Growth inhibition assay |
|
|
|
Inhibition of human CFPAC-1 cell growth in a cell viability assay, IC50=6.38606μM. |
SANGER |
KU812 |
Growth inhibition assay |
|
|
|
Inhibition of human KU812 cell growth in a cell viability assay, IC50=7.31846μM. |
SANGER |
L-428 |
Growth inhibition assay |
|
|
|
Inhibition of human L-428 cell growth in a cell viability assay, IC50=7.64645μM. |
SANGER |
LU-65 |
Growth inhibition assay |
|
|
|
Inhibition of human LU-65 cell growth in a cell viability assay, IC50=7.66066μM. |
SANGER |
KY821 |
Growth inhibition assay |
|
|
|
Inhibition of human KY821 cell growth in a cell viability assay, IC50=9.74408μM. |
SANGER |
HCC1569 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1569 cell growth in a cell viability assay, IC50=10.3717μM. |
SANGER |
OE33 |
Growth inhibition assay |
|
|
|
Inhibition of human OE33 cell growth in a cell viability assay, IC50=11.9163μM. |
SANGER |
NCI-H460 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50=11.9629μM. |
SANGER |
CCRF-CEM |
Growth inhibition assay |
|
|
|
Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50=12.0256μM. |
SANGER |
MFH-ino |
Growth inhibition assay |
|
|
|
Inhibition of human MFH-ino cell growth in a cell viability assay, IC50=12.2311μM. |
SANGER |
HCC1954 |
Growth inhibition assay |
|
|
|
Inhibition of human HCC1954 cell growth in a cell viability assay, IC50=12.6636μM. |
SANGER |
SW948 |
Growth inhibition assay |
|
|
|
Inhibition of human SW948 cell growth in a cell viability assay, IC50=14.1953μM. |
SANGER |
NCI-H82 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H82 cell growth in a cell viability assay, IC50=14.6264μM. |
SANGER |
KM-H2 |
Growth inhibition assay |
|
|
|
Inhibition of human KM-H2 cell growth in a cell viability assay, IC50=15.7903μM. |
SANGER |
OE19 |
Growth inhibition assay |
|
|
|
Inhibition of human OE19 cell growth in a cell viability assay, IC50=16.5176μM. |
SANGER |
COLO-320-HSR |
Growth inhibition assay |
|
|
|
Inhibition of human COLO-320-HSR cell growth in a cell viability assay, IC50=16.92μM. |
SANGER |
NCI-H441 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H441 cell growth in a cell viability assay, IC50=20.1493μM. |
SANGER |
A388 |
Growth inhibition assay |
|
|
|
Inhibition of human A388 cell growth in a cell viability assay, IC50=21.4044μM. |
SANGER |
NCI-H1993 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1993 cell growth in a cell viability assay, IC50=22.4278μM. |
SANGER |
LS-1034 |
Growth inhibition assay |
|
|
|
Inhibition of human LS-1034 cell growth in a cell viability assay, IC50=23.2936μM. |
SANGER |
NCI-H1666 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1666 cell growth in a cell viability assay, IC50=33.2038μM. |
SANGER |
NCI-H1975 |
Growth inhibition assay |
|
|
|
Inhibition of human NCI-H1975 cell growth in a cell viability assay, IC50=35.902μM. |
SANGER |